Hypervirulent Klebsiella pneumoniae causing aortitis retains its capsule and mucoviscosity and remains genotypically

Thomas A Russo1,2,3,4,5, Ulrike Carlino-MacDonald6,7, Zachary J Drayer7

  • 1The Veterans Administration Western New York Healthcare System, 3495 Bailey Ave, Buffalo, NY, 14215, USA. trusso@buffalo.edu.

Scientific Reports
|November 13, 2025
PubMed

Insights

Hypervirulent Klebsiella pneumoniae (hvKp) caused aortitis. The capsule-positive, mucoviscous phenotype persisted during treatment, suggesting it’s crucial for infection survival and may require prolonged therapy with adjunctive treatments.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Vascular Surgery

Background:

  • Aortitis is a severe infection affecting the aorta.
  • Hypervirulent Klebsiella pneumoniae (hvKp) is an emerging pathogen causing invasive infections.
  • The role of hvKp virulence factors in systemic infections like aortitis is not fully understood.

Purpose of the Study:

  • To characterize hvKp isolates from a patient with aortitis.
  • To investigate the in vitro and in vivo stability of hvKp virulence factors during antimicrobial therapy.
  • To understand the role of capsular polysaccharide and mucoviscosity in hvKp pathogenesis.

Main Methods:

  • Genomic and phenotypic characterization of hvKp isolates.
  • In vitro studies of capsule-deficient mutants.
  • Assessment of bacterial resistance to phagocytosis and complement-mediated bactericidal activity.

Main Results:

  • The hvKp isolate remained genomically and phenotypically unchanged after prolonged antimicrobial therapy, retaining its capsule and mucoviscosity.
  • Capsule-deficient mutants were generated in vitro, but the capsule-positive phenotype was selected for in vivo.
  • Capsule-positive strains showed resistance to phagocytosis but increased sensitivity to complement-mediated killing compared to capsule-minus strains.

Conclusions:

  • The capsule-positive, mucoviscous phenotype of hvKp is stable and selected for during systemic infection.
  • Phagocytosis resistance is a key defense mechanism for hvKp in the systemic compartment.
  • Prolonged antimicrobial therapy and potential adjunctive treatments are likely necessary for hvKp aortitis.

Related Concept Videos

Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
2.6K
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K